Copilot
Your everyday AI companion
About 162,000 results
Open links in new tab
  1. Hearing Health & Technology Matters
    https://hearinghealthmatters.org/hea…

    Frequency Therapeutics to Discontinue FX-322 Hearing Loss …

    Frequency Therapeutics announced that its drug candidate FX-322 failed to improve speech perception in a Phase 2b trial for sensorineural hearing loss. The company will also stop developing FX-345 and focus on remyelination for multiple sclerosis.
  2. Yahoo Finance
    https://finance.yahoo.com/news/freque…

    Frequency Therapeutics Inc (FREQ) Announces Merger …

    WEBNov 6, 2023 · Korro Bio, a biopharmaceutical company developing RNA editing therapies, has completed its merger with Frequency Therapeutics and raised $117 million in a private placement. The …

  3. MIT News
    https://news.mit.edu/2022/frequency-th…

    Reversing hearing loss with regenerative therapy - MIT …

    WEBMar 29, 2022 · Frequency Therapeutics is a biotechnology company that uses small molecules to stimulate progenitor cells in the inner ear to grow hair cells. The company has conducted several clinical trials and …

  5. Business Wire
    https://www.businesswire.com/news/home/20221012005144/en

    Frequency Therapeutics Completes Enrollment of Phase 2b Study …

    Tags:
    Frequency Therapeutics
    FX-322
    Sensorineural hearing loss
    Business Wire
  6. Yahoo Finance
    https://finance.yahoo.com/news/astellas-pharma...

    Astellas Pharma and Frequency Therapeutics collaborate on …

    Tags:
    Frequency Therapeutics
    FX-322
    Hearing Loss
    Astellas Pharma
  7. SciTechDaily
    https://scitechdaily.com/mit-scientists-de…

    MIT Scientists Develop New Regenerative Drug That

    WEBApr 9, 2022 · Frequency Therapeutics is a biotech company that develops drugs to rebuild hair cells in the inner ear using small molecules. The company has shown promising results in clinical trials …

    Tags:
    Frequency Therapeutics
    MIT Reverse Hearing Loss
    MIT Hearing Regeneration
  8. People also ask
    What is Frequency Therapeutics?
    About Frequency Therapeutics Headquartered in Lexington, Mass., Frequency Therapeutics is pioneering a new category in regenerative medicine that aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body through the activation of progenitor cells.

    Frequency Therapeutics to Discontinue FX-322 Hearing Loss Treatment

    hearinghealthmatters.org
    How much money will Frequency Therapeutics receive?
    Frequency Therapeutics is to receive $80M, followed by up to $545M in future milestone payments as well as royalties on sales outside the US. Sensorineural hearing loss, the most common form of hearing loss, occurs when inner ear hair cells become lost or damaged.

    Astellas Pharma and Frequency Therapeutics collaborate on hearing los…

    finance.yahoo.com
    Who are Frequency Therapeutics co-founders?
    Frequency Therapeutics co-founders Will McLean, PhD recipient at the Harvard-MIT Division of Health Sciences and Technology (HST), David Lucchino MBA ’06, Jeff Karp, PhD, HST affiliate faculty and Professor at Brigham and Women’s Hospital, and Chris Loose, PhD ’07. Frequency went public on the Nasdaq on October 3, 2019.

    Reversing hearing loss with regenerative therapy | MIT News

    news.mit.edu
    Why did Frequency Therapeutics stop developing FX-322?
    Frequency Therapeutics announced Monday it will scrap development of a drug called FX-322, after testing failed to show improvement in speech perception in people with noise-induced sensorineural hearing loss. Photo courtesy of Frequency Therapeutics

    Hearing loss treatment scrapped as drug company announces 'disappoi…

    upi.com
    Feedback
  9. Business Wire
    https://www.businesswire.com/news/home/20210922005242/en

    Frequency Therapeutics Announces New FX-322 Results Showing …

    Tags:
    Frequency Therapeutics
    FX-322
  10. UPI
    https://www.upi.com/Health_News/202…

    Hearing loss treatment scrapped as drug company …

    WEBFeb. 13 (UPI) -- Regenerative medicine company Frequency Therapeutics announced Monday it will scrap development of a drug called FX-322, after testing failed to show improvement in speech...

    Tags:
    Frequency Therapeutics
    FX-322
    Hearing Loss
    Sheri Walsh
  11. Hearing Health & Technology Matters
    https://hearinghealthmatters.org/thiswee…

    An Update on Frequency Therapeutics Clinical Trials of …

    WEBDec 27, 2022 · Frequency Therapeutics is a biotech company developing drugs to restore hearing using regenerative medicine. Learn about their clinical trials of FX-322 and FX-345, two potential treatments for …

    Tags:
    Frequency Therapeutics Fx 322
    Frequency Therapeutics Fx-322 Phase 2
  12. Chemical & Engineering News
    https://cen.acs.org/articles/95/i16/Frequency...

    Frequency-Therapeutics-launches-tackle-hearing

    Tags:
    Frequency Therapeutics
    Hearing Loss
    Lisa M. Jarvis